Jump to the top of the page

Showing 680 – 690 of 1304 results

  • Oak Street Health Inc Initiation

    William Blair & Company initiated research coverage of Oak Street Health, Inc. (OSH $44.56), a fast-growing network of value-based primary care centers for adults on Medicare.

  • Lyra Therapeutics Inc Initiation

    William Blair & Company initiated research coverage of Lyra Therapeutics, Inc. (LYRA $14.90), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the treatment of patients with ear, nose, and throat (ENT) diseases.

  • Lemonade Inc Initiation

    William Blair & Company initiated research coverage of Lemonade, Inc. (LMND $82.16), a digital-first insurance provider, offering both homeowners and renters insurance domestically and internationally.

  • Sumo Logic Inc Initiation

    William Blair & Company initiated research coverage of Sumo Logic, Inc. (SUMO $24.20). Sumo Logic is a next-generation provider of observability, monitoring, and security solutions through its Continuous Intelligence Platform.

  • Prevail Therapeutics Inc Initiation

    William Blair & Company initiated research coverage of Prevail Therapeutics Inc. (PRVL $11.90), a clinical-stage company developing adeno-associated virus (AAV) gene therapies for neurodegenerative disorders of the central nervous system.

  • Kristina Blaschek

    View biography for Kristina Blaschek, Director of Business and Technology Solutions.

  • Korea Stewardship Code

    William Blair is a signatory to the Korea Stewardship Code.

  • Braming Named to Forbes 50 Over 50 List

    Stephanie Braming, CFA, partner, global head of William Blair Investment Management, has been named to Forbes’ fourth annual 50 Over 50 list, which is dedicated to spotlighting women across industries.

  • Butterfly Network Inc Initiation

    William Blair initiated research coverage of Butterfly Network, Inc. (BFLY $2.55), a pioneer of digital ultrasound technology that is disrupting conventional medical imaging with its proprietary Ultrasound-on-Chip technology.

  • Viking Therapeutics Intelligent Capital Driving Clinical Research

    Within the uber-competitive biotech industry, the race for capital and research supremacy is as tough as ever. Viking Therapeutics founder Dr. Brian Lian explains how they have found success and have been able to stay focused on the big picture.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures